COMMUNIQUÉS West-GlobeNewswire

OraSure Technologies to Present at the LEERINK 7th Annual Global Healthcare Conference

08/02/2018 - 12:00

BETHLEHEM, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, [...]

Onconova Therapeutics Announces Pricing of $8.7 Million Underwritten Public Offering

08/02/2018 - 12:00

NEWTOWN, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]

Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.

08/02/2018 - 11:56

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc. Paris - February 8, 2018 - Sanofi announced today that on February 7, 2018 it commenced a tender [...]

Sanofi lance l'offre publique d'achat en vue de l'acquisition de Bioverativ Inc

08/02/2018 - 11:56

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi lance l'offre publique d'achat en vue de l'acquisition de Bioverativ Inc Paris - Le 8 février 2018 - Sanofi annonce aujourd'hui que l'offre publique d' [...]

Green Cures & Botanical Distribution, Inc. Begins Development on Two New Original Hollywood Hemp Product Lines

08/02/2018 - 11:30

LOS ANGELES, CA , Feb. 08, 2018 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution, Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body care products company, has begun [...]

LIDDS: Liproca® Depot effects on prostate cancer to be presented at the Paris Symposium for Magnetic Resonance in Medicine

08/02/2018 - 08:30

The scientific results from intratumoral injections with Liproca® Depot as confirmed by Magnetic Resonance Imaging and Spectroscopy, have been accepted for presentation at the International Society for Magnetic [...]

Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application

08/02/2018 - 08:01

Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application Herantis Pharma Plc Company release 8 Feb 2018 at 9:00 am Herantis [...]

ERYTECH to Present at the 2018 BIO CEO & Investor Conference

08/02/2018 - 07:31

ERYTECH to Present at the 2018 BIO CEO & Investor Conference LYON, France - February 8, 2018 - ERYTECH Pharma (Euronext Paris: ERYP, Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative [...]

Novartis receives FDA approval for Cosentyx® label update to include moderate-to-severe scalp psoriasis

08/02/2018 - 07:16

US label updated to include Cosentyx ® (secukinumab) data in moderate-to-severe scalp psoriasis[1] - one of the difficult-to-treat types of psoriasis[2] Approximately half of all 125 million patients with psoriasis [...]

VIFOR PHARMA FERROPORTIN INHIBITOR ENTERS PHASE-I CLINICAL TRIAL

08/02/2018 - 06:59

vifor pharma announced today that vit-2763, the first-ever oral ferroportin inhibitor for preventing iron overload, will enter clinical development with a phase-i study at the beginning of March 2018. first results from [...]

Ligandal CEO Unveils Nanotech Delivery for Genetic Therapies: “What Good Would Amazon Be Without the Shipping?”

08/02/2018 - 02:08

SAN DIEGO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cures for sickle cell, hemophilia and a host of other genetic-based diseases are on the horizon because of nanotechnology that can now deliver CRISPR , mRNA, and other [...]

First Choice Healthcare Solutions Announces Strategic Partnership and Equity Investment with Steward Health Care

08/02/2018 - 01:46

Management to Host Shareholder Update Conference Call to Discuss Strategic Partnership in Further Detail on Thursday, February 8th at 11:00 a.m. ET MELBOURNE, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- First Choice [...]

MediciNova Announces Pricing of Underwritten Public Offering of Common Stock

08/02/2018 - 01:12

LA JOLLA, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Gemphire Announces Proposed Public Offering of Common Stock

07/02/2018 - 22:32

LIVONIA, Mich., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]

Precision Optics Corporation Schedules Second Quarter Conference Call

07/02/2018 - 22:30

GARDNER, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the "Company") announced that it intends to release its financial results for the fiscal year 2018 second quarter ended [...]

Akari Therapeutics to Present at the Leerink Partners Global Healthcare Conference

07/02/2018 - 22:30

NEW YORK and LONDON, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ: AKTX ) (“Akari” or “the Company”), a biopharmaceutical company focused on the development and commercialization of innovative [...]

Tonix Pharmaceuticals to Present at the 20th Annual BIO CEO & Investor Conference in New York City

07/02/2018 - 22:30

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat [...]

Insmed to Present at the Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 22:30

BRIDGEWATER, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that Will Lewis, [...]

Prothena to Participate in the Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 22:05

DUBLIN, Ireland, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in [...]